key: cord-0874454-9dgf5ral
authors: Mohananey, Divyanshu; Sarau, Alexandra; Kumar, Rohit; Lewandowski, David; Abreu-Sosa, Sol M.; Nathan, Sunita; Okwuosa, Tochukwu M.
title: Role of Physical Activity and Cardiac Rehabilitation in Patients Undergoing Hematopoietic Stem Cell Transplantation
date: 2021-03-16
journal: JACC CardioOncol
DOI: 10.1016/j.jaccao.2021.01.008
sha: bcf12d6e74c365a0cd801d401822e88c504d8b5b
doc_id: 874454
cord_uid: 9dgf5ral

Hematopoietic stem cell transplantation (HSCT) is a standard treatment for several malignancies, and >50,000 HSCT are performed annually worldwide. As survival after HSCT improves, cardiovascular disease and associated risk factors have gained importance as a significant cause of morbidity and mortality in this cohort. In this article, we detail the risk factors for cardiovascular disease and their impact in patients undergoing HSCT. Additionally, we critically review the data on the impact of physical exercise in patients undergoing HSCT. Although limited by significant heterogeneity in methodologies, small sample sizes, attrition, and lack of long-term cardiovascular follow-up, most of these studies reinforce the beneficial effects of physical activity and exercise in this patient population. Cardiac rehabilitation (CR) is a structured exercise and lifestyle modification program that is typically instituted in patients who experience acute cardiovascular events. We review the data on CR in the oncologic and nononcologic populations with an aim of building a framework for use of CR in HSCT patients.

HSCT survivors (3) (4) (5) . However, the noted improvement in survival after HSCT has been associated with a resultant increased risk of non-disease-specific long-term complications. Specifically, the burden of cardiovascular disease (CVD) and associated risk factors have a significant adverse impact on long-term morbidity and mortality after HSCT (6) .

The Centers for Disease Control and Prevention regards physical activity as an effective form of treatment for and prevention of chronic diseases including CVD, metabolic syndrome, and certain cancers in the general population (7) . These data suggest that physical activity leads to improvements not only from a physiological perspective but also from an overall health-related quality of life perspective (8) . Cardiac rehabilitation (CR) is a structured comprehensive exercise and lifestyle modification program that is extensively used in cardiovascular practice after myocardial infarction (MI) as well as in patients with stable angina or heart failure and after percutaneous coronary interventions (PCI) and cardiac surgery.

In this review, we comprehensively evaluate published reports on the feasibility, implementation, and outcomes of exercise therapy and cardiac rehabilitation, and we propose a framework to implement these strategies in the growing HSCT population.

Although HSCT has significantly enhanced the potential for cure and survival in patients with hematologic malignancies, long-term survival after HSCT is dependent on several factors including patient characteristics, prior cancer treatment, disease risk stratification, and transplant-related outcomes. In a large cohort of patients who were alive and disease free after 2 years of allogeneic HSCT, the 10-year probability of survival was 85% (3) . Similarly, the 20-year survival was 80% in patients who were relapse free for $5 years after autologous HSCT (9) . However, long-term CVD and CVD risk factors are a major cause of morbidity and mortality among these survivors, often relating to prior cancer treatment in addition to cardiovascular issues associated with HSCT. HSCT recipients are at increased risk of developing CVD risk factors, with reported incidence rates for hypertension of 28% to 74%; diabetes, 10% to 41%; dyslipidemia, 33% to 58%; and obesity, 20% to 44%. This translates into a 7-to 16-fold higher incidence of CVD risk factors in HSCT survivors compared to the general population (10) (11) (12) .

Similarly, HSCT survivors have an increased risk of overt CVD with a reported incidence of MI, heart failure, and arrhythmias of 1% to 6%, 1% to 9%, and 2% to 13%, respectively (11) (12) (13) (14) (15) (16) , with a median age for overt CVD lower in HSCT survivors compared to the general population (age 54 years vs. 67 years, respectively) (11, 17, 18) . Furthermore, there is a 2-to 4-fold increased risk of CVD mortality in HSCT survivors compared with the general population (15, 19) .

Although advanced age is a well-established independent risk factor for CVD (20) , improvements in HSCT techniques have made it possible to offer HSCT to the geriatric population. To this end, in 2018, 39% of allogeneic HSCT and 55% of autologous HSCT recipients were in patients ages 60 years and older (2) .

HSCT recipients is likely a consequence of direct organ damage from therapeutic exposure to chemotherapy and/or radiation, as well as indirect injury from graftversus-host disease (GVHD), pre-existing CVD risk factors, and functional disability (16) . Heart failure has been associated with chemotherapeutic agents such as anthracyclines (3% to 26%) and high-dose cyclophosphamide (28%) used as part of primary treatment or preparative regimens (20) (21) (22) (23) . Compared to autologous HSCT, higher incidence of cardiovascular risk factors like hypertension, diabetes, and dyslipidemia has been reported in allogeneic HSCT survivors (10) .

These risk factors are particularly more prevalent in patients who develop GVHD, and it has been hypothesized that the allogeneic reaction may cause an HIGHLIGHTS Patients surviving HSCT have a higher incidence of cardiovascular risk factors and cardiovascular disease than the general population.

Physical activity can improve cardiovascular fitness, strength, and quality of life and decrease fatigue in HSCT patients and survivors.

In addition to physical exercise, cardiac rehabilitation also involves dietary and smoking cessation counseling, medication management, and psychosocial support, and it may therefore offer a unique framework to mitigate cardiovascular risk in HSCT.

Early referral, cardiovascular risk stratification, monitoring for complications, and multimodal lifestyle interventions should form the backbone of cardiac rehabilitation in this population.

Outcome data on quality of life indices and survival as potential benefits of cardiac rehabilitation in HSCT are needed. accelerated atherosclerotic process (10) . Moreover, in an analysis of 123 HSCT survivors, of whom 95.9% underwent allogeneic transplantation and all were treated with total-body irradiation, the 10-year cumulative incidences of elevated blood pressure, elevated glucose, low high-density lipoprotein cholesterol, hypertriglyceridemia, and obesity were 8.8%, 33.1%, 52.0%, 65.0%, and 18.6%, respectively (24) . Furthermore, HSCT recipients require an average of 4 or more weeks of inpatient hospital stay. During this prolonged stay, patients are often critically ill, lose muscle mass, and may develop decreased exercise capacity (16) . Although there is a paucity of data on the effects of prolonged inpatient stay on CVD sequelae in HSCT patients, the impact may be extrapolated from studies in nononcologic patients.

One such study reported that a 3-week bed rest may lead to similar deterioration in cardiopulmonary fitness as a 40-year-period aging process (25,26). The impact of prolonged bed rest on cardiopulmonary fitness in HSCT recipients is likely to be more pronounced, given associated higher CVD risks, than in otherwise healthy individuals.

The physical activity guidelines by a federal advisory committee and the U.S. Department of Health and Human Services recommend for Americans that adults engage in at least 150 to 300 min of moderateintensity or 75 to 150 min of vigorous-intensity aerobic physical activity per week, as well as musclestrengthening activities 2 or more days a week (27 Table 1 ). In particular, the exclusion of patients with CVD is of special concern because these patients may benefit most from physical activity.

Another limitation of these studies is that they do not specifically evaluate the association of physical ac- Physical Activity and Cardiac Rehabilitation in HSCT Other conditions specific to the HSCT population that may limit the use of VO 2 max as an outcome measure are neutropenia, isolation during hospitalization, and presence of mucositis that prevents patients from holding a mouthpiece (53, 75) . Only 2 randomized trials used VO 2 max for assessment of cardiorespiratory function (36, 49) . Of these, the study by Jarden et al. They reported that patients in the supervised group increased their 6-minute walk distance and 50-foot walk time, whereas the self-directed group increased only their 6-minute walk distance (37) . At the same time, supervised interventions that may be effective during hospitalization may not show continued benefit at long-term follow-up (36) . A Cochrane review for the general population suggested that a mixture of professional guidance and self-direction plus ongoing professional support leads to more consistent effects (76) . A unique approach to this combined intervention was undertaken by Hacker et al. (47) In that study, patients underwent supervised exercise once or twice a week during their regularly scheduled clinic visits.

Patients were encouraged to exercise on their own 2 more times per week for a total of 3 times per week.

They postulated that this approach would reduce the risk of exposure to pathogens in places such as gyms and make effective use of clinic waiting times (47) . 

CR is a structured exercise and lifestyle modification program that is typically instituted in patients who experience acute cardiovascular events. The incorporation of CR services in the health care of patients with coronary heart disease, especially following an acute MI, has become recognized as a Class I recommendation from several societies, including the American Heart Association (AHA) and the American College of Cardiology (77) . Multiple meta-analyses and systematic reviews have analyzed the benefits of CR in this population (Supplemental Table 1 The CR program typically begins with an initial assessment during hospitalization, followed by program initiation 1 to 2 weeks after discharge (80) . At the initial assessment, patients are risk stratified based on their degree of medical illness to help determine the necessary level of supervision and program intensity. The duration and frequency of programs vary but typically involve 3 sessions per week for 12 weeks (79) . These variables can be generally tailored to patient preference with equal efficacy (81) . The intention is that once the program is completed, the patient will be able to continue selfmotivated exercise and risk factor modification.

There are exercise-only programs and programs with and without psychosocial support; some of the programs are unsupervised, or "home CR."

Contraindications to the exercise component of CR include unstable angina, decompensated heart failure, ventricular arrhythmias, severe pulmonary hypertension, intracavitary thrombus, or severe valve disease (82) . Patients at high risk for complications (AHA class C) are advised to undergo exercise in a supervised environment with electrocardiogram monitoring at a facility able to provide advanced life support. Once the initial program is completed, a recommendation is then provided for continued unsupervised exercise based on the patient's performance (83) . For patients at lower risk, however, unsupervised exercise provides an attractive flexible option. Ideally, the first few weeks are completed with supervision to evaluate for complications, and afterward, patients are provided specific instructions for activity and heart rate monitoring. HOME-BASED CR AND TELEMEDICINE. Home-based CR has been demonstrated to be similar to groupbased CR in terms of outcomes, safety, and cost, with superior adherence (84) , and has gained even more importance during the coronavirus disease-2019 pandemic, with a global transition toward virtual care and telemedicine. Nonetheless, it is essential to recognize that although patients at high cardiovascular risk are also at high risk for coronavirus infection, exercise in these higher-risk patients without direct supervision is a daunting prospect, with few data to guide this approach (85) . Several strategies could be used to aid with success in home-based CR, including wearable heart monitors, smartphone applications, and video observation by a CR therapist with coaching (86) . In a study on HSCT patients at intermediate to high risk of CVD, Chang et al. (87) piloted a 4-week remote monitoring program using blood pressure monitoring, pulse oximetry, and glucometer. There was $80% compliance in this study, with at least two thirds of patients successfully performing $3 readings per week, thereby demonstrating the feasibility of a home monitoring program (87) . However, data are insufficient to support improvement in short-or longterm outcomes for these patients using telemedicine.

Additionally, it is important to recognize that the availability and usability of these technologies may be limited in the highest-risk population, that is, those from poor socioeconomic strata, in older age groups, and with physical impairments or lack of adequate social and family support. the CR program >30 days after their initial assessment have less beneficial outcomes compared to those who entered earlier (92) . Furthermore, the nonexercise components of CR will need to be adapted to fit a different archetype. For example, the incidence of current cigarette smoking in HSCT patients is around 7% to 17% compared to 37% in patients presenting with MI (93) . Similarly, nutritional advice will also need to be tailored carefully to each patient, because many HSCT patients may be underweight post-transplant as opposed to overweight, with significant nutritional deficiencies (94) .

Other factors that may complicate recovery and initiation or continuation of CR in the HSCT population include GVHD and musculoskeletal pathology such as bone lesions in multiple myeloma. Along with an increase in morbidity and mortality, patients with GVHD have significantly lower quality of life scores and functional capacity compared to patients without (95) . Consequently, patients with GVHD may not be able to tolerate an exercise regimen (95) and potential spinal instability. It is critical that each patient with spinal involvement be evaluated before initiation of CR, with an exercise prescription tailored as such in a monitored setting. Patients with high-risk lesions may not be appropriate for exercise therapy but could be after treatment (98) . Scoring systems could be used to help predict which patients may be at highest risk, taking into account location, pain, imaging characteristics, and spinal alignment. Physical therapists could also design exercise that minimizes spinal load to reduce risk (99) . Although data are limited, the available published reports suggest that exercise is feasible and safe in patients with multiple myeloma (100) . In a small randomized controlled trial of 30 patients with multiple myeloma, patients were randomized to usual care versus an exercise routine. Two-thirds (67%) of these patients had bone disease, and some had their exercise routine modified to account for it. None of the patients in either arm experienced any adverse events attributed to physical activity (101).

There are also potential setbacks with treatment.

Patients may suffer relapses that could preclude them from continuing CR. Complications could also arise with immunosuppressive therapy. Steroid use could lead to avascular necrosis or steroid myopathy, which Mohananey et al. Physical Activity and Cardiac Rehabilitation in HSCT framework for physical, emotional, and nutritional rehabilitation for this population.

The authors have reported that they have nor relationships relevant to the contents of this paper to disclose. 

Haematopoietic stem cell transplantation HSCtx

Current use of and trends in hematopoietic cell transplantation in the United States

Long-term survival and late deaths after allogeneic hematopoietic cell transplantation

Prevalence of hematopoietic cell transplant survivors in the United States

Long-term health impacts of hematopoietic stem cell transplantation inform recommendations for follow-up

Physical activity level and health-related quality of life in the general adult population: a systematic review

Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation

Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease

Predictors of late cardiovascular complications in survivors of hematopoietic cell transplantation

Late cardiovascular complications after hematopoietic cell transplantation

Late congestive heart failure after hematopoietic cell transplantation

Influence of conventional cardiovascular risk factors and lifestyle characteristics on cardiovascular disease after hematopoietic cell transplantation

Cardiovascular hospitalizations and mortality among recipients of hematopoietic stem cell transplantation

Cardiovascular disease following hematopoietic stem cell transplantation: pathogenesis, detection, and the cardioprotective role of aerobic training

Cardiovascular disease after hematopoietic cell transplantation-lessons learned

ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines

Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study

Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management

Cardiotoxicity associated with high-dose cyclophosphamide therapy

Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation

Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS)

Cardiovascular risk factors in survivors of childhood hematopoietic cell transplantation treated with total body irradiation: a longitudinal analysis

A forty-year follow-up of the Dallas Bed Rest and Training study: the effect of age on the cardiovascular response to exercise in men

The physical activity guidelines for Americans

Exercise guidelines for cancer survivors: consensus statement from International Multidisciplinary Roundtable

Exercise is medicine in oncology: engaging clinicians to help patients move through cancer

Role of physical therapy before and after hematopoietic stem cell transplantation: white paper report

Effects of resistive exercise on skeletal muscle in marrow transplant recipients receiving total parenteral nutrition

Effects of exercise in combination with epoetin alfa during high-dose chemotherapy and autologous peripheral blood stem cell transplantation for multiple myeloma

Effects of exercise on fatigue, sleep, and performance: a randomized trial

Feasibility of exercise during treatment for multiple myeloma

A randomized trial on the effect of a multimodal intervention on physical capacity, functional performance and quality of life in adult patients undergoing allogeneic SCT

A randomized control trial of a supervised versus a self-directed exercise program for allogeneic stem cell transplant patients

Effects of an exercise program on muscle performance in patients undergoing allogeneic bone marrow transplantation

A controlled randomized study examining the effects of exercise therapy on patients undergoing haematopoietic stem cell transplantation

Rehabilitation programme after stem cell transplantation: randomized controlled trial

Effects of an outpatient physical exercise program on hematopoietic stem-cell transplantation recipients: a randomized clinical trial

Strength training following hematopoietic stem cell transplantation

Telephone-delivered nutrition and exercise counselling after auto-SCT: a pilot, randomised controlled trial

Exercise and stress management training prior to hematopoietic cell transplantation: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902

Effects of a partly self-administered exercise program before, during, and after allogeneic stem cell transplantation

Multimodal exercise training during myeloablative chemotherapy: a prospective randomized pilot trial

Strength training to enhance early recovery after hematopoietic stem cell transplantation

A prospective, randomized evaluation of the feasibility of exergaming on patients undergoing hematopoietic stem cell transplantation

Randomized controlled trial on the effects of a supervised high intensity exercise program in patients with a hematologic malignancy treated with autologous stem cell transplantation: results from the EXIST study

Individualized exercise program for the treatment of severe fatigue in patients after allogeneic hematopoietic stem-cell transplant: a pilot study

An aerobic exercise program for patients with haematological malignancies after bone marrow transplantation

Effects of physical activity on the fatigue and psychologic status of cancer patients during chemotherapy

Aerobic exercise in the rehabilitation of cancer patients after high dose chemotherapy and autologous peripheral stem cell transplantation

Quality of life changes following peripheral blood stem cell transplantation and participation in a mixed-type, moderate-intensity, exercise program

The impact of early rehabilitation on the duration of hospitalization in patients after allogeneic hematopoietic stem cell transplantation

Safety and feasibility of physical therapy in cytopenic patients during allogeneic haematopoietic stem cell transplantation

Effects of physical exercise on survival after allogeneic stem cell transplantation

Pretransplantation exercise and hematopoietic cell transplantation survival: a secondary analysis of Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0902)

Feasibility of an exercise programme in elderly patients undergoing allogeneic stem cell transplantation-a pilot study

A hospital and home-based exercise program to address functional decline in people following allogeneic stem cell transplantation

Relationship of physical activity with physical function and health-related quality of life in patients having undergone allogeneic haematopoietic stemcell transplantation

Lessons learnt from a process evaluation of an exercise intervention in patients treated with autologous stem cell transplantation

Physical exercise prior to hematopoietic stem cell transplantation: a feasibility study

Effects of exercise in patients treated with stem cell transplantation for a hematologic malignancy: a systematic review and meta-analysis

Exercise for physical fitness, fatigue and quality of life of patients undergoing hematopoietic stem cell transplantation: a meta-analysis of randomized controlled trials

Physical activity reduces fatigue in patients with cancer and hematopoietic stem cell transplant recipients: a systematic review and meta-analysis of randomized trials

Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902)

Prognostic significance of pre-transplant quality of life in allogeneic hematopoietic cell transplantation recipients

Centralized patient-reported outcome data collection in transplantation is feasible and clinically meaningful

Physiologic frailty as a sign of accelerated aging among adult survivors of childhood cancer: a report from the St Jude Lifetime cohort study

Frailty: the missing piece of the pre-hematopoietic cell transplantation assessment?

Geriatric syndromes in 2-year, progression-free survivors among older recipients of allogeneic hematopoietic cell transplantation

Maximal oxygen uptake

Clinician's guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association

Interventions for promoting physical activity

AACVPR/ACC/AHA 2007 performance measures on cardiac rehabilitation for referral to and delivery of cardiac rehabilitation/secondary prevention services

Cardiac rehabilitation and secondary prevention of coronary heart disease: an American Heart Association scientific statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity), in collaboration with the American association of Cardiovascular and Pulmonary Rehabilitation

Cardiac rehabilitation programs

ACC/AHA clinical performance and quality measures for cardiac rehabilitation: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures

Impact of program duration and contact frequency on efficacy and cost of cardiac rehabilitation: results of a randomized trial

27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 1. Pathogenesis of coronary disease: the biologic role of risk factors

Stop waiting and start creating: service learning with an outpatient bone marrow transplant unit art cart program

Homebased cardiac rehabilitation for people with heart failure: a systematic review and meta-analysis

Cardiac rehabilitation during the COVID-19 era: guidance on implementing virtual care

COVID-19: a time for alternate models in cardiac rehabilitation to take centre stage

Feasibility and acceptability of using a telehealth platform to monitor cardiovascular risk factors in hematopoietic cell transplantation survivors at risk for cardiovascular disease

Cardiooncology rehabilitation to manage cardiovascular outcomes in cancer patients and survivors: a scientific statement from the American Heart Association

Integrating rehabilitation into the cancer care continuum

Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation

Cardiac rehabilitation in patients with lymphoma undergoing autologous hematopoietic stem cell transplantation: a cardio-oncology pilot project

Effect of early enrollment on outcomes in cardiac rehabilitation

Association of smoking status with angina and health-related quality of life after acute myocardial infarction

Comprehensive evaluation of nutritional status before and after hematopoietic stem cell transplantation in 170 patients with hematological diseases

Quality of life associated with acute and chronic graft-versushost disease

Physical function and quality of life in patients with chronic GvHD: a summary of preclinical and clinical studies and a call for exercise intervention trials in patients

Multiple myeloma and physical activity: a scoping review

Perspectives on spinal precautions in patients who have cancer and spinal metastasis

The effectiveness of exercise programmes in patients with multiple myeloma: a literature review